Antiinflammatory effects of l-carnitine supplementation (1000 mg/d) in coronary artery disease patients
Tài liệu tham khảo
Tracy, 2002, Inflammation in cardiovascular disease: cart, horse or both-revisited, Arterioscler Thromb Vasc Biol, 22, 1514, 10.1161/01.ATV.0000035403.39442.DB
Ross, 1999, Atherosclerosis: an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207
Ridker, 2000, Plasma concentration of interleukin-6 and the risk future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767
Pearson, 2003, Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45
Gurrola-Díaz, 2009, Establishment of a cut-point value of serum TNF-alpha levels in the metabolic syndrome, J Clin Lab Anal, 23, 51, 10.1002/jcla.20289
Kendler, 1986, Carnitine: an overview of its role in preventive medicine, Prev Med, 15, 373, 10.1016/0091-7435(86)90005-8
Flanagan, 2010, Role of carnitine in disease, Nutr Metab, 7, 30, 10.1186/1743-7075-7-30
Koc, 2011, Effect of L-carnitine on the synthesis of nitric oxide in RAW 264 A7 murine macrophage cell line, Cell Biochem Funct, 29, 679, 10.1002/cbf.1807
Moeinian, 2013, Synergistic effect of probiotics, butyrate and L-Carnitine in treatment of IBD, JMHI, 7, 50
Savica, 2005, L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients, J Ren Nutr, 15, 225, 10.1053/j.jrn.2004.10.002
Duranay, 2006, Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients, Nephrol Dial Transplant, 21, 3211, 10.1093/ndt/gfl356
Shakeri, 2010, Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia, Hemodial Int, 14, 498, 10.1111/j.1542-4758.2010.00476.x
Tabibi, 2011, Effects of L-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial, J Ren Nutr, 21, 485, 10.1053/j.jrn.2011.01.001
Botsoglou, 1994, Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples, J Agric Food Chem, 42, 1931, 10.1021/jf00045a019
Paglia, 1967, Studies on the qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med, 70, 159
Marklund, 1974, Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur J Biochem, 47, 469, 10.1111/j.1432-1033.1974.tb03714.x
Aebi, 1984, Catalase in vitro, Methods Enzymol, 105, 121, 10.1016/S0076-6879(84)05016-3
Lysiak, 1988, Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria, J Biol Chem, 263, 1151, 10.1016/S0021-9258(19)57279-9
Broderick, 1992, Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart, J Biol Chem, 267, 3758, 10.1016/S0021-9258(19)50590-7
Gülçin, 2006, Antioxidant and antiradical activities of L-carnitine, Life Sci, 78, 803, 10.1016/j.lfs.2005.05.103
Kolodziejczyk, 2011, L-Carnitine protects plasma components against oxidative alterations, Nutrition, 27, 693, 10.1016/j.nut.2010.06.009
Mingorance, 2011, Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders, Vasc Health Risk Manag, 7, 169
Binienda, 2001, Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity, Toxicol Lett, 125, 67, 10.1016/S0378-4274(01)00415-5
Augustyniak, 2010, The influence of L-carnitine supplementation on the antioxidative abilities of serum and the central nervous system of ethanol-induced rats, Metab Brain Dis, 25, 381, 10.1007/s11011-010-9217-7
Miguel-Carrasco, 2010, Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats, Eur J Pharmacol, 632, 65, 10.1016/j.ejphar.2010.01.017
Li, 2012, Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha, J Biomed Sci, 19, 32, 10.1186/1423-0127-19-32
Lee, 2014, Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial, Nutr J, 13, 79, 10.1186/1475-2891-13-79
Setia, 2012, Nuclear factor kappa B: a pro-inflammatory, transcription factor-mediated signaling pathway in lung carcinogenesis and its inhibition by nonsteroidal antiinflammatory drugs, J Environ Pathol Toxicol Oncol, 31, 27, 10.1615/JEnvironPatholToxicolOncol.v31.i1.40
Siomek, 2012, NF-κB signaling pathway and free radical impact, Acta Biochim Pol, 59, 323, 10.18388/abp.2012_2116
Conner, 1996, Inflammation, free radicals, and antioxidants, Nutrition, 12, 274, 10.1016/S0899-9007(96)00000-8
Kurutas, 2005, Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis, Mediators Inflamm, 2005, 390, 10.1155/MI.2005.390
Cetinkaya, 2006, Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis, Dig Dis Sci, 51, 488, 10.1007/s10620-006-3160-9
Volek, 2008, Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults, Am J Cardiol, 102, 1413, 10.1016/j.amjcard.2008.07.022
Tarighat Esfanjani, 2012, The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis, Biol Trace Elem Res, 150, 42, 10.1007/s12011-012-9487-5
Tayebi Khosroshahi, 2013, Comparison of vitamin e and L-carnitine, separately or in combination in patients with intradialytic complications, Nephrourol Mon, 5, 862, 10.5812/numonthly.10670
Bonafé, 2014, Carnitine deficiency in chronic critical illness, Curr Opin Clin Nutr Metab Care, 17, 200, 10.1097/MCO.0000000000000037
Rubin, 2001, Safety measures of L-carnitine L-tartrate supplementation in healthy men, J Strength Cond Res, 15, 486
Cruciani, 2006, Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study, J Pain Symptom Manage, 32, 551, 10.1016/j.jpainsymman.2006.09.001
Puskarich, 2013, Preliminary Safety and Efficacy of L-carnitine Infusion for the Treatment of Vasopressor-Dependent Septic Shock: a randomized control trial, J Parenter Enteral Nutr, 20, 1
Zhang, 2014, Safety and efficacy of L-carnitine and tadalafil for late-onset hypogonadism with ED: a randomized controlled multicenter clinical trial, Zhonghua Nan Ke Xue, 20, 133
Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat Med, 19, 576, 10.1038/nm.3145
McCarty, 2013, L-carnitine consumption, its metabolism by intestinal microbiota, and cardiovascular health, Mayo Clin Proc, 88, 786, 10.1016/j.mayocp.2013.06.004
Singh, 1998, L-carnitine administration in coronary artery disease and cardiomyopathy, J Assoc Physicians India, 46, 801